Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SU5416 in Advanced Colorectal Cancer
NCT00006001Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Aug 2000
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of semaxanib in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Aug 2000; status: terminated.
02
Drugs
semaxanib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00006001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006001.